ZHONGSHENGYAOYE(002317.SZ)

Last Updated 00:00:00
longbridge loading

In half a day, the main funds increased their positions in the pharmaceutical and biotechnology sector while selling off the electronics sector

36Kr·
SH
600157
-2.75%
SZ
000547
-2.73%
SZ
002317
+3.94%
36Kr·
SH
600157
-2.75%
SZ
000547
-2.73%
SZ
002317
+3.94%

ZHONGSHENGYAOYE: Net profit in the third quarter was 62.6822 million yuan, a year-on-year increase of 2.10%

Zhitong·
SZ
002317
+3.94%
Zhitong·
SZ
002317
+3.94%

ZHONGSHENGYAOYE: Subsidiary receives approval notice for the listing application of polyvinyl alcohol chemical raw materials

Zhitong·
SZ
002317
+3.94%
Zhitong·
SZ
002317
+3.94%

ZHONGSHENGYAOYE's subsidiary has obtained ethical approval for the Phase III clinical trial of the innovative drug Anglatide granules

Zhitong·
SZ
002317
+3.94%
Zhitong·
SZ
002317
+3.94%

ZHONGSHENGYAOYE released its performance for the first half of the year, with a net profit attributable to the parent company of 188 million yuan, a year-on-year increase of 114.96%

Zhitong·
SZ
002317
+3.94%
Zhitong·
SZ
002317
+3.94%

ZHONGSHENGYAOYE: The first participant has been enrolled in the Phase III clinical trial of RAY1225 injection for glycemic reduction

Zhitong·
SZ
002317
+3.94%
Zhitong·
SZ
002317
+3.94%

Huaxin Securities: New drug overseas licensing revenue is gradually confirmed, and the pharmaceutical industry ecosystem continues to improve

Zhitong·
SH
603259
+1.29%
HK
02359
+2.54%
SZ
002317
+3.94%
Zhitong·
SH
603259
+1.29%
HK
02359
+2.54%
SZ
002317
+3.94%

The A-share traditional Chinese medicine sector rapidly surged, with Xintian Pharma hitting the limit up, and YIBAI PHARMACEUTICAL, Zhendong Pharmacy, ZHONGSHENGYAOYE, Hansen Pharmaceutical, and ENWEI PHARMACEUTICAL following suit

Zhitong·
SZ
301331
-0.30%
SZ
002873
-1.43%
SZ
300158
-1.75%
Zhitong·
SZ
301331
-0.30%
SZ
002873
-1.43%
SZ
300158
-1.75%

Cathay Securities and Haitong Securities: The first year of commercialization for domestic innovative weight loss drugs, there are still many catalysts for related companies in the future

Zhitong·
HK
03933
-1.77%
HK
02105
-0.91%
SZ
002317
+3.94%
Zhitong·
HK
03933
-1.77%
HK
02105
-0.91%
SZ
002317
+3.94%

A-shares closing: The ChiNext Index surged 1.86%, with pharmaceutical stocks experiencing a widespread breakout

Wallstreetcn·
SZ
002370
-4.33%
SH
603773
+9.94%
SH
688020
+0.54%
Wallstreetcn·
SZ
002370
-4.33%
SH
603773
+9.94%
SH
688020
+0.54%
© 2026 Longbridge｜Disclaimer